VIM and neoplasm: In most cases, tumor samples from patients with high vimentin expression exhibited low MAP17 expression (Fig. 6A, case 8 and case 39) and samples from patients with low vimentin expression exhibited high MAP17 expression (Fig. 6A, case 10 and case 21).